Weed (BUDZ) Change in Receivables (2018 - 2019)

Weed (BUDZ) recorded quarterly Change in Receivables of $423.0 in Q2 2019, up 11.9% quarter-over-quarter from $378.0 in Q1 2019.

Weed (BUDZ) Change in Receivables (2018 - 2019) Analysis & Trends

Weed's Change in Receivables history runs 2 years deep, the most recent figure standing at $423.0 for Q2 2019.

In Q2 2019, Change in Receivables changed N/A year-over-year to $423.0; the TTM figure through Mar 2020 stood at $423.0 (up 6.02% YoY), while the FY2019 annual figure was $801.0, up 3714.29% from the prior year.
Change in Receivables was $423.0 for Q2 2019 at Weed, up from $378.0 in the prior quarter.
In the past five years, Change in Receivables ranged from a high of $423.0 in Q2 2019 to a low of $21.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-78.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	106.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-38.20 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	81.40 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	23.22 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	116.25 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	2.23 Mn
10	Weed	-	-	-	-

Download Data